4.7 Article

Correcting common errors in identifying cancer-specific serum peptide signatures

期刊

JOURNAL OF PROTEOME RESEARCH
卷 4, 期 4, 页码 1060-1072

出版社

AMER CHEMICAL SOC
DOI: 10.1021/pr050034b

关键词

serum; biomarkers; peptides; patterns; bias; mass spectrometry; peak alignment; specimen collection; sample processing

资金

  1. NCI NIH HHS [P50 CA092629, P30 CA 08748, P30 CA008748] Funding Source: Medline

向作者/读者索取更多资源

' Molecular signatures ' are the qualitative and quantitative patterns of groups of biomolecules (e.g., mRNA, proteins, pepticles, or metabolites) in a cell, tissue, biological fluid, or an entire organism. To apply this concept to biomarker discovery, the measurements should ideally be noninvasive and performed in a single read-out. We have therefore developed a pepticlomics platform that couples magnetics-based, automated solid-phase extraction of small peptides with a high-resolution MALDITOF mass spectrometric readout (Villanueva, J.; Philip, J.; Entenberg, D.; Chaparro, C. A.; Tanwar, M. K.; Holland, E. C.; Tempst, P. Anal. Chem. 2004, 76, 1560-1570). Since hundreds of peptides can be detected in microliter volumes of serum, it allows to search for disease signatures, for instance in the presence of cancer. We have now evaluated, optimized, and standardized a number of clinical and analytical chemistry variables that are major sources of bias; ranging from blood collection and clotting, to serum storage and handling, automated pepticle extraction, crystallization, spectral acquisition, and signal processing. In addition, proper alignment of spectra and user-friendly visualization tools are essential for meaningful, certifiable data mining. We introduce a minimal entropy algorithm, ' Entropycal ', that simplifies alignment and subsequent statistical analysis and increases the percentage of the highly distinguishing spectral information being retained after feature selection of the datasets. Using the improved analytical platform and tools, and a commercial statistics program, we found that sera from thyroid cancer patients can be distinguished from healthy controls based on an array of 98 discriminant peptides. With adequate technological and computational methods in place, and using rigorously standardized conditions, potential sources of patient related bias (e.g., gender, age, genetics, environmental, dietary, and other factors) may now be addressed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据